Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture

Gut

Volumn 66, Issue 8, 2017, Pages 1487-1495

  Piver, Eric ^a,b   Boyer, Audrey ^a,c   Gaillard, Julien ^a   Bull, Anne ^a   Beaumont, Elodie ^a   Roingeard, Philippe ^a   Meunier, Jean Christophe ^a  

^a UNIVERSITÉ DE TOURS   (France)

^b SERVICE DE DERMATOLOGIE   (France)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

HCV; HEPATITIS C; IMAGING; INFECTIOUS DISEASE; LIPID METABOLISM

Indexed keywords

APOLIPOPROTEIN B; APOLIPOPROTEIN E; LIPID; PROTEIN E1E2; UNCLASSIFIED DRUG; VIRUS GLYCOPROTEIN; ANTIBODY; E1E2 PEPTIDE; PEPTIDE; VIRUS RNA;

ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOCAPTURE; IMMUNOELECTRON MICROSCOPY; LIPID COMPOSITION; LIPID MEMBRANE; LIPO VIRUS PARTICLE; LIVER FIBROSIS; MOLECULAR BIOLOGY; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS MORPHOLOGY; VIRUS NUCLEOCAPSID; VIRUS PARTICLE; BLOOD; CHRONIC HEPATITIS C; HEPACIVIRUS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; PROCEDURES; ULTRASTRUCTURE; VIROLOGY;

ANTIBODIES; APOLIPOPROTEINS B; APOLIPOPROTEINS E; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; NUCLEOCAPSID; PEPTIDES; RNA, VIRAL;

EID: 84991773772     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2016-311726     Document Type: Article

References (26)

1. André P, Komurian-Pradel F, Deforges S, et al. Characterization of low-And very-low-density hepatitis C virus RNA-containing particles. J Virol 2002;76:6919-28.
2. Aizawa Y, Seki N, Nagano T, et al. Chronic hepatitis C virus infection and lipoprotein metabolism. World J Gastroenterol 2015;21:10299-313.
3. Fukuhara T, Ono C, Puig-Basagoiti F, et al. Roles of Lipoproteins and Apolipoproteins in Particle Formation of Hepatitis C Virus. Trends Microbiol 2015;23:618-29.
4. Gastaminza P, Cheng G, Wieland S, et al. Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion. J Virol 2008;82:2120-9.
5. Gastaminza P, Kapadia SB, Chisari FV. Differential biophysical properties of infectious intracellular and secreted hepatitis C virus particles. J Virol 2006;80:11074-81.
6. Huang H, Sun F, Owen DM, et al. Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins. Proc Natl Acad Sci USA 2007;104:5848-53.
7. Popescu CI, Riva L, Vlaicu O, et al. Hepatitis C virus life cycle and lipid metabolism. Biology (Basel) 2014;3:892-921.
8. Thomssen R, Bonk S, Propfe C, et al. Association of hepatitis C virus in human sera with β-lipoprotein. Med Microbiol Immunol (Berl) 1992;181:293-300.
9. Thomssen R, Bonk S, Thiele A. Density heterogeneities of hepatitis C virus in human sera due to the binding of β-lipoproteins and immunoglobulins. Med Microbiol Immunol (Berl) 1993;182:329-34.
10. Catanese MT, Uryu K, Kopp M, et al. Ultrastructural analysis of hepatitis C virus particles. Proc Natl Acad Sci USA 2013;110:9505-10.
11. Gastaminza P, Dryden KA, Boyd B, et al. Ultrastructural and biophysical characterization of hepatitis C virus particles produced in cell culture. J Virol 2010;84:10999-1009.
12. Kaito M, Watanabe S, Tsukiyama-Kohara K, et al. Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 1994;75(Pt 7):1755-60.
13. Li X, Jeffers LJ, Shao L, et al. Identification of hepatitis C virus by immunoelectron microscopy. J Viral Hepat 1995;2:227-34.
14. Maillard P, Krawczynski K, Nitkiewicz J, et al. Nonenveloped nucleocapsids of hepatitis C virus in the serum of infected patients. J Virol 2001;75:8240-50.
15. Trestard A, Bacq Y, Buzelay L, et al. Ultrastructural and physicochemical characterization of the hepatitis C virus recovered from the serum of an agammaglobulinemic patient. Arch Virol 1998;143:2241-5.
16. Yu X, Qiao M, Atanasov I, et al. Cryo-electron microscopy and three-dimensional reconstructions of hepatitis C virus particles. Virology 2007;367:126-34.
17. Giang E, Dorner M, Prentoe JC, et al. Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus. Proc Natl Acad Sci USA 2012;109:6205-10.
18. Bartosch B, Dubuisson J, Cosset FL. Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes. J Exp Med 2003;197:633-42.
19. Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 2005;11:791-6.
20. Ferraris P, Beaumont E, Uzbekov R, et al. Sequential biogenesis of host cell membrane rearrangements induced by hepatitis C virus infection. Cell Mol Life Sci 2013;70:1297-306.
21. Merz A, Long G, Hiet MS, et al. Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome. J Biol Chem 2011;286:3018-32.
22. Felmlee DJ, Sheridan DA, Bridge SH, et al. Intravascular transfer contributes to postprandial increase in numbers of very-low-density hepatitis C virus particles. Gastroenterology 2010;139:1774-83, 1783.e1-6.
23. Icard V, Diaz O, Scholtes C, et al. Secretion of hepatitis C virus envelope glycoproteins depends on assembly of apolipoprotein B positive lipoproteins. PLoS ONE 2009;4:e4233.
24. Scholtes C, Ramière C, Rainteau D, et al. High plasma level of nucleocapsid-free envelope glycoprotein-positive lipoproteins in hepatitis C patients. Hepatology 2012;56:39-48.
25. Prince AM, Huima-Byron T, Parker TS, et al. Visualization of hepatitis C virions and putative defective interfering particles isolated from low-density lipoproteins. J Viral Hepat 1996;3:11-7.
26. Boyer A, Dumans A, Beaumont E, et al. The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles. J Biol Chem 2014;289:18904-13.